NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

62.06 +0.18 (+0.30%)
At close: November 21 at 3:54 PM EST

Top 10 Holdings (23.63% of Total Assets)

SymbolCompany% Assets
TVTX
Travere Therapeutics, Inc. 3.59%
ALNY
Alnylam Pharmaceuticals, Inc. 2.48%
PHAT
Phathom Pharmaceuticals, Inc. 2.33%
ZLAB
Zai Lab Limited 2.28%
ADMA
ADMA Biologics, Inc. 2.25%
EXEL
Exelixis, Inc. 2.25%
TGTX
TG Therapeutics, Inc. 2.22%
MIRM
Mirum Pharmaceuticals, Inc. 2.14%
GILD
Gilead Sciences, Inc. 2.08%
AUPH
Aurinia Pharmaceuticals Inc. 2.00%

Sector Weightings

Overall Portfolio Composition (%)

Stocks 99.20%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.23
Price/Sales 0.15
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

ETF Overview

Category Health
Fund Family Virtus
Net Assets 22.14M
YTD Daily Total Return 6.51%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers